1 / 25

Group 1 PAH: Current Therapies

Group 1 PAH: Current Therapies. Group 4 CTEPH. Prostacyclin Pathway: Modulation by Available Agents. SERAPHIN: Primary End Point*. Prostacyclin Pathway: Modulation by Investigational Agents. CTEPH: Lung Tissue Samples Show Distal Arteriopathy.

gloria-owens
Télécharger la présentation

Group 1 PAH: Current Therapies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Group 1 PAH: Current Therapies

  2. Group 4 CTEPH

  3. Prostacyclin Pathway: Modulation by Available Agents

  4. SERAPHIN: Primary End Point*

  5. Prostacyclin Pathway: Modulation by Investigational Agents

  6. CTEPH: Lung Tissue Samples Show Distal Arteriopathy

  7. Recent/Ongoing Trials: Address Previously Unmet Needs

  8. Use of Other PAH Therapies

  9. PATENT-1: Hypotension

  10. Angiogenesis and PDGF: Modulation by Tyrosine Kinase Inhibitors

  11. PATENT-1 and SERAPHIN at ESC

  12. References

  13. References (cont)

  14. References (cont)

  15. Abbreviations

  16. Abbreviations (cont)

More Related